Filing Details

Accession Number:
0001209191-17-037922
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-06-05 18:05:13
Reporting Period:
2017-06-01
Filing Date:
2017-06-05
Accepted Time:
2017-06-05 18:05:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
875320 Vertex Pharmaceuticals Inc / Ma VRTX Pharmaceutical Preparations (2834) 043039129
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1197032 F Ian Smith C/O Vertex Pharmaceuticals Incorporated
50 Northern Avenue
Boston MA 02210
Evp, Cfo & Coo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-06-01 37,383 $45.11 163,621 No 4 M Direct
Common Stock Acquisiton 2017-06-01 18,124 $48.74 181,745 No 4 M Direct
Common Stock Acquisiton 2017-06-01 23,789 $37.86 205,534 No 4 M Direct
Common Stock Acquisiton 2017-06-01 9,062 $51.75 214,596 No 4 M Direct
Common Stock Acquisiton 2017-06-01 10,195 $38.80 224,791 No 4 M Direct
Common Stock Disposition 2017-06-01 98,553 $124.00 126,238 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2017-06-01 37,383 $0.00 37,383 $45.11
Common Stock Stock Option (Right to Buy) Disposition 2017-06-01 18,124 $0.00 18,124 $48.74
Common Stock Stock Option (Right to Buy) Disposition 2017-06-01 23,789 $0.00 23,789 $37.86
Common Stock Stock Option (Right to Buy) Disposition 2017-06-01 9,062 $0.00 9,062 $51.75
Common Stock Stock Option (Right to Buy) Disposition 2017-06-01 10,195 $0.00 10,195 $38.80
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2023-02-04 No 4 M Direct
0 2022-07-24 No 4 M Direct
0 2022-02-01 No 4 M Direct
0 2021-07-12 No 4 M Direct
0 2021-02-02 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 5,306 Indirect 401(k)
Footnotes
  1. Transaction made pursuant to Mr. Smith's company approved trading plan under Rule 10b5-1.
  2. Fully vested.